Dihydroberberine
Dihydroberberine is a naturally occurring isoquinoline alkaloid with anti-inflammatory, anti-atherosclerotic, hypolipidemic and anti-tumor activities. Dihydroberberine inhibits the human ether-related gene (hERG) channel and significantly reduces the expression of heat shock protein 90 (Hsp90) and its interaction with hERG. Dihydroberberine also blocks the TLR4/MyD88/NF-κB signaling pathway to reduce pro-inflammatory cytokines and immunoglobulins, and has inhibitory effects on DSS -induced experimental colitis. Dihydroberberine also increases the sensitivity of lung cancer to sunitinib (HY-10255A), with synergistic efficacy[1][2].
Product Specifications
CAS Number
483-15-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HSP; Potassium Channel
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/dihydroberberine.html
Purity
99.30
Solubility
DMSO : 20 mg/mL (ultrasonic; warming; heat to 70°C)
Smiles
COC1=CC=C(C=C23)C(CN2CCC(C3=C4)=CC5=C4OCO5)=C1OC
Molecular Formula
C20H19NO4
Molecular Weight
337.37
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
HSP90
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin 3 (KRT3) (Corneal Epithelial Marker) (KRT3/2130), CF594 conjugate, 0.1mg/mL
Inositol Hexakisphosphate Kinase 2 (IP6K2) (NM_001005909) Human Over-expression Lysate
XPG (ERCC5) (NM_000123) Human Over-expression Lysate
